INmune Bio: A Novel Approach Towards Treating Alzheimer’s Disease

Alzheimer’s Disease

Alzheimer’s Disease has proven very difficult to treat through many of the trials’ attempts by both small and large biotechnology and biopharmaceutical companies. Analysts and investors are skeptical about all promised successes in defeating this disease.

However,  knowing that we are in the middle of a biological scientific revolution we are keeping our eyes and ears open each and every time a firm, small or large, comes up with a new scientific approach for the treatment of this catastrophic condition.

Leave a Reply